Renovia, a women-led company that develops digital therapeutics for female pelvic floor disorders, today announced the appointment of Eileen Maus in Q4 2020 as the company’s president and CEO. Under her leadership, Renovia completed patient enrollment in its all-virtual randomized control trial (RCT) for the leva Digital Therapeutic one month ahead of schedule. Ms. Maus is an accomplished leader in women’s health and has directed the success…
Kountable and Proof Market announce a strategic alliance to source and deliver Diabetes, COVID-19, and other rapid diagnostic test kits to women across Low and Middle Income Countries. The alliance will empower one billion women in developing countries including Africa, India, and the Middle East with access to the highest quality rapid diagnostic test kits they need, at the price, volume, and…
In our “Starter Story” series we invite femtech founders to share their stories of how it all began. How did they come up with the idea? Where did they meet their cofounders and what was the hardest part of going from 0 to 1? In today’s Starter Story we get to share VagiPlug’s founding story as told by Founder Teneha Brown. Vagiplug‘s mission…
While cancer therapies are getting more personalized (and expensive), patient outcomes don’t seem to improve along the same trajectory and SynDevRx believes to know why that is. According to the company’s research the answer lies in the way that obesity, diabetes, and other forms of metabolic dysfunction accelerate tumor growth and metastasis, making at least 13 common types of cancer much more…
Nuvo Group, the private company commercializing INVU by Nuvo, an FDA-cleared, prescription-initiated, remote pregnancy monitoring platform, recently announced that it has filed a 510(k) notice with the U.S. Food and Drug Administration (FDA) to add a new uterine activity module that provides capability for remote monitoring of maternal uterine activity (MUA). INVU has already received FDA clearance for remote monitoring and measurement of fetal and…
Tia recently announced the opening of its second location in Los Angeles. While in-person care will officially start in March 2021, virtual care is available as of now. Tia is known for championing the concept of “Whole Person Health” and aims to recreate a healthcare system that was designed for specialties, body parts, and treating sickness. The company announced the close of…
Pregna has recently announced the launch of its cryotherapy device CryoPop. The product was developed by Jhpiego with an objective of making treatment of cervical pre-cancerous lesions accessible to all. Pregna is the exclusive global commercialising partner for the device. “Cervical cancer is one of the most common and fatal forms of cancer in women worldwide, with about 85% of these deaths occurring in low and…
Runway Growth Capital, a provider of growth loans to both venture and non-venture backed companies seeking an alternative to raising equity, announced today the closing of a senior secured term loan of $50 million to Gynesonics, a healthcare company focused on advancing women’s health by developing minimally invasive, incision-free, uterus-preserving, transcervical technologies for diagnostic and therapeutic applications. Gynesonics has developed and has received FDA clearance for…
